| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Prevention of HIV-1 infection with early antiretroviral therapy.
|
N Engl J Med
|
2011
|
69.36
|
|
2
|
Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women.
|
AIDS
|
2006
|
4.23
|
|
3
|
Antiretroviral treatment for children with peripartum nevirapine exposure.
|
N Engl J Med
|
2010
|
3.81
|
|
4
|
Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.
|
J Infect Dis
|
2005
|
3.59
|
|
5
|
LigAmp for sensitive detection of single-nucleotide differences.
|
Nat Methods
|
2004
|
2.70
|
|
6
|
Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.
|
N Engl J Med
|
2012
|
2.50
|
|
7
|
Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.
|
Lancet
|
2011
|
2.49
|
|
8
|
HIV incidence determination in the United States: a multiassay approach.
|
J Infect Dis
|
2012
|
2.47
|
|
9
|
Correlates of HIV acquisition in a cohort of Black men who have sex with men in the United States: HIV prevention trials network (HPTN) 061.
|
PLoS One
|
2013
|
2.32
|
|
10
|
Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay.
|
AIDS
|
2014
|
2.18
|
|
11
|
Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.
|
J Virol
|
2007
|
2.14
|
|
12
|
Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D.
|
J Acquir Immune Defic Syndr
|
2006
|
1.94
|
|
13
|
Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1.
|
J Infect Dis
|
2009
|
1.93
|
|
14
|
HIV-1 tropism and survival in vertically infected Ugandan infants.
|
J Infect Dis
|
2008
|
1.83
|
|
15
|
Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052).
|
J Infect Dis
|
2013
|
1.77
|
|
16
|
Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission.
|
J Infect Dis
|
2007
|
1.73
|
|
17
|
Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission.
|
J Infect Dis
|
2008
|
1.70
|
|
18
|
Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay.
|
AIDS Res Hum Retroviruses
|
2011
|
1.66
|
|
19
|
Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection.
|
Clin Infect Dis
|
2013
|
1.64
|
|
20
|
HIV acquisition among women from selected areas of the United States: a cohort study.
|
Ann Intern Med
|
2013
|
1.59
|
|
21
|
Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis.
|
AIDS
|
2011
|
1.59
|
|
22
|
Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial.
|
Arch Intern Med
|
2009
|
1.54
|
|
23
|
A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease.
|
J Infect Dis
|
2003
|
1.51
|
|
24
|
Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries.
|
AIDS Res Hum Retroviruses
|
2012
|
1.50
|
|
25
|
Evaluation of the editing process in human immunodeficiency virus type 1 genotyping.
|
J Clin Microbiol
|
2003
|
1.46
|
|
26
|
Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection.
|
PLoS One
|
2011
|
1.46
|
|
27
|
Estimation of HIV incidence using multiple biomarkers.
|
Am J Epidemiol
|
2013
|
1.43
|
|
28
|
Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043).
|
PLoS One
|
2013
|
1.40
|
|
29
|
HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388.
|
Clin Infect Dis
|
2004
|
1.39
|
|
30
|
Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.
|
PLoS One
|
2013
|
1.35
|
|
31
|
Cross-sectional HIV incidence estimation in HIV prevention research.
|
J Acquir Immune Defic Syndr
|
2013
|
1.31
|
|
32
|
Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months.
|
J Acquir Immune Defic Syndr
|
2003
|
1.30
|
|
33
|
Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D.
|
J Mol Diagn
|
2006
|
1.25
|
|
34
|
Use of single-dose nevirapine for the prevention of mother-to-child transmission of HIV-1: does development of resistance matter?
|
Am J Obstet Gynecol
|
2007
|
1.25
|
|
35
|
Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial.
|
PLoS One
|
2013
|
1.24
|
|
36
|
Analysis of HIV diversity using a high-resolution melting assay.
|
AIDS Res Hum Retroviruses
|
2010
|
1.23
|
|
37
|
Association of HIV diversity and survival in HIV-infected Ugandan infants.
|
PLoS One
|
2011
|
1.23
|
|
38
|
Infrequent HIV testing and late HIV diagnosis are common among a cohort of black men who have sex with men in 6 US cities.
|
J Acquir Immune Defic Syndr
|
2014
|
1.17
|
|
39
|
Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity.
|
J Clin Microbiol
|
2012
|
1.17
|
|
40
|
Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda.
|
J Acquir Immune Defic Syndr
|
2009
|
1.08
|
|
41
|
Impact of mutation type and amplicon characteristics on genetic diversity measures generated using a high-resolution melting diversity assay.
|
J Mol Diagn
|
2012
|
1.08
|
|
42
|
Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial.
|
Clin Infect Dis
|
2010
|
1.07
|
|
43
|
Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants.
|
Clin Infect Dis
|
2011
|
1.07
|
|
44
|
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.
|
J Infect Dis
|
2013
|
1.06
|
|
45
|
Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.
|
AIDS Res Hum Retroviruses
|
2013
|
1.05
|
|
46
|
Analysis of insertions and deletions in the gag p6 region of diverse HIV type 1 strains.
|
AIDS Res Hum Retroviruses
|
2004
|
1.05
|
|
47
|
HIV-1 transmission during early antiretroviral therapy: evaluation of two HIV-1 transmission events in the HPTN 052 prevention study.
|
PLoS One
|
2013
|
1.04
|
|
48
|
Analysis of HIV using a high resolution melting (HRM) diversity assay: automation of HRM data analysis enhances the utility of the assay for analysis of HIV incidence.
|
PLoS One
|
2012
|
1.02
|
|
49
|
Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine.
|
AIDS
|
2007
|
1.02
|
|
50
|
Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life.
|
J Acquir Immune Defic Syndr
|
2014
|
1.01
|
|
51
|
Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results.
|
AIDS
|
2005
|
1.01
|
|
52
|
One-, two-, and three-class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India.
|
AIDS Res Hum Retroviruses
|
2010
|
1.01
|
|
53
|
Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children.
|
Pediatr Infect Dis J
|
2012
|
0.99
|
|
54
|
In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.
|
AIDS Res Hum Retroviruses
|
2009
|
0.98
|
|
55
|
Comparison of LigAmp and an ASPCR assay for detection and quantification of K103N-containing HIV variants.
|
AIDS Res Hum Retroviruses
|
2008
|
0.98
|
|
56
|
A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.
|
HIV Seq Compend
|
2001
|
0.98
|
|
57
|
HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043).
|
BMC Infect Dis
|
2011
|
0.97
|
|
58
|
HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm.
|
J Clin Microbiol
|
2013
|
0.95
|
|
59
|
Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061.
|
J Acquir Immune Defic Syndr
|
2015
|
0.94
|
|
60
|
Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.
|
J Acquir Immune Defic Syndr
|
2014
|
0.93
|
|
61
|
HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D.
|
AIDS Res Hum Retroviruses
|
2007
|
0.93
|
|
62
|
Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individuals.
|
AIDS Res Hum Retroviruses
|
2009
|
0.92
|
|
63
|
Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero.
|
AIDS
|
2010
|
0.91
|
|
64
|
Vertical transmission of X4-tropic and dual-tropic HIV-1 in five Ugandan mother-infant pairs.
|
AIDS
|
2009
|
0.90
|
|
65
|
The effect of sample handling on cross sectional HIV incidence testing results.
|
PLoS One
|
2011
|
0.90
|
|
66
|
Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda.
|
AIDS Res Hum Retroviruses
|
2013
|
0.90
|
|
67
|
Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settings.
|
J Clin Microbiol
|
2011
|
0.90
|
|
68
|
Low-level Viremia early in HIV infection.
|
J Acquir Immune Defic Syndr
|
2014
|
0.89
|
|
69
|
Association of recent HIV infection and in-utero HIV-1 transmission.
|
AIDS
|
2011
|
0.89
|
|
70
|
Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmission.
|
Pediatr Infect Dis J
|
2014
|
0.88
|
|
71
|
Antibody maturation and viral diversification in HIV-infected women.
|
PLoS One
|
2013
|
0.88
|
|
72
|
Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda.
|
AIDS Res Hum Retroviruses
|
2010
|
0.87
|
|
73
|
Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq).
|
AIDS Res Hum Retroviruses
|
2008
|
0.87
|
|
74
|
Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission.
|
J Infect Dis
|
2008
|
0.87
|
|
75
|
Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay.
|
PLoS One
|
2010
|
0.86
|
|
76
|
Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D.
|
J Acquir Immune Defic Syndr
|
2006
|
0.86
|
|
77
|
Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV.
|
HIV Clin Trials
|
2008
|
0.86
|
|
78
|
Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay.
|
J Acquir Immune Defic Syndr
|
2014
|
0.84
|
|
79
|
Experience in international clinical research: the HIV Prevention Trials Network.
|
Clin Investig (Lond)
|
2011
|
0.84
|
|
80
|
Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration.
|
AIDS
|
2010
|
0.84
|
|
81
|
Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants.
|
Pediatr Infect Dis J
|
2013
|
0.84
|
|
82
|
Determination of HIV Status in African Adults With Discordant HIV Rapid Tests.
|
J Acquir Immune Defic Syndr
|
2015
|
0.84
|
|
83
|
Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection.
|
J Infect Dis
|
2010
|
0.83
|
|
84
|
Efficiency of CCR5 coreceptor utilization by the HIV quasispecies increases over time, but is not associated with disease progression.
|
AIDS Res Hum Retroviruses
|
2011
|
0.82
|
|
85
|
Antiretroviral drug susceptibility among HIV-infected adults failing antiretroviral therapy in Rakai, Uganda.
|
AIDS Res Hum Retroviruses
|
2012
|
0.82
|
|
86
|
Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infants.
|
AIDS Res Hum Retroviruses
|
2009
|
0.81
|
|
87
|
Association of pol diversity with antiretroviral treatment outcomes among HIV-infected African children.
|
PLoS One
|
2013
|
0.81
|
|
88
|
Analysis of HIV type 1 gp41 and enfuvirtide susceptibility among men in the United States who were HIV infected prior to availability of HIV entry inhibitors.
|
AIDS Res Hum Retroviruses
|
2009
|
0.80
|
|
89
|
Analysis of length variation in the V1-V2 region of env in nonsubtype B HIV type 1 from Uganda.
|
AIDS Res Hum Retroviruses
|
2002
|
0.80
|
|
90
|
Mother-to-child transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1.
|
AIDS Res Hum Retroviruses
|
2002
|
0.80
|
|
91
|
Characterization of HIV seroconverters in a TDF/FTC PrEP study: HPTN 067/ADAPT.
|
J Acquir Immune Defic Syndr
|
2017
|
0.80
|
|
92
|
Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial.
|
J Acquir Immune Defic Syndr
|
2016
|
0.79
|
|
93
|
Analysis of PTAP duplications in the gag p6 region of subtype C HIV type 1.
|
AIDS Res Hum Retroviruses
|
2005
|
0.79
|
|
94
|
HIV type 1 polymerase gene polymorphisms are associated with phenotypic differences in replication capacity and disease progression.
|
J Infect Dis
|
2013
|
0.79
|
|
95
|
Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis.
|
PLoS Med
|
2015
|
0.78
|
|
96
|
Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D.
|
AIDS Res Hum Retroviruses
|
2014
|
0.78
|
|
97
|
Analysis of HIV tropism in Ugandan infants.
|
Curr HIV Res
|
2010
|
0.78
|
|
98
|
Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants.
|
J Acquir Immune Defic Syndr
|
2012
|
0.78
|
|
99
|
Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.
|
AIDS Res Hum Retroviruses
|
2005
|
0.78
|
|
100
|
Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure.
|
AIDS Res Hum Retroviruses
|
2012
|
0.78
|
|
101
|
Antiretroviral drug use in a cross-sectional population survey in Africa: NIMH Project Accept (HPTN 043).
|
J Acquir Immune Defic Syndr
|
2016
|
0.78
|
|
102
|
Evaluation of postpartum HIV superinfection and mother-to-child transmission.
|
AIDS
|
2015
|
0.77
|
|
103
|
Phenotypic Coreceptor Tropism in Perinatally HIV-infected Youth Failing Antiretroviral Therapy.
|
Pediatr Infect Dis J
|
2016
|
0.75
|
|
104
|
Impact of early antiretroviral therapy on the performance of HIV rapid tests and HIV incidence assays.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|
|
105
|
A Comparison of Hepatitis B Virus Infection in HIV-infected and HIV-uninfected Participants Enrolled in a Multi-National Clinical Trial: HPTN 052.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|